Sandoz Group

SDZ · SIX · CHF

CHF 68,42Variação em relação ao fechamento anterior: −3,44%Variação absoluta: −CHF 2,44

Fechamento · 1 de outubro de 2026

Perfil da empresa

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Descrição disponível em inglês.

Dados da empresa

Setor
Saúde
Indústria
Drug Manufacturers - Specialty & Generic
País
Suíça
Sede
Centralbahnstrasse 4, 4051, Basel
Funcionários
20.000
Listagem
SDZ · SIX
Índices
SMI
Moeda
CHF
ISIN
CH1243598427